At Metric Bio, we have a commitment to the continuous development of long-lasting, meaningful relationships through trust, honest communication and shared goals to ensure a sustainable and successful future for all our candidates and clients. Alex Alves-Khan is a testament to this value at Metric Bio and we’re not the only ones that think so. Why not read below about Kyle J. Lauterbach, MBA, PMP’s experience with Alex Alves-Khan in securing him a position at Scorpius BioManufacturing, Inc., and visit Alex's webpage to read more about his track record. https://lnkd.in/dzBW-RXn #MetricBio #Testimony #ScorpiusBioManufacturing
Metric Bio’s Post
More Relevant Posts
-
Drumrolls 🥁 Here's the 10th post from our Pitch Deck Redesign series! This time, we redesigned a few slides from Pepper Bio's Seed Deck. Take a look, and let us know if you would like us to redesign your deck. Which redesigned slide did you like the most? #goodmadebetter #pitchdeckredesign #biotech #drugdiscovery #seedfunding
-
This webinar explains some of the reasons Parse Evercode implementation is expanding rapidly for single cell RNA sequencing programs by pharma. #singlecellanalysis #parsebiosciences #rna #cellandgenetherapy #immunotherapy #immunology #ngs
Did you miss our recent webinar on scaling your scRNA-seq experiments with Parse Evercode? You can now watch the full webinar on demand: https://parse.bio/47l1ZFy
[On-Demand Webinar] Scaling Your scRNA-Seq Experiments with Evercode™
-
So many biocatalysis projects end up failing because they were just not meant to be. When it comes to enzyme development, it’s hard to make the right decision without having clarity on the chances of success. Specially, with no reliable data. In the last few months, at ZYMVOL we’ve been envisioning the way to use our prediciting capabilities to solve this issue. And finally, today, we’re presenting #Zymplifier. Zymplifier is our data-driven approach to help all those innovators in the field of green chemistry find out the most promising opportunities in their enzyme development portfolio. Have a look at Zymplifier and start betting on what is most likely to succeed. 👉 https://lnkd.in/d4ACXiQP
-
-
Of course many Enzyme Development projects fail. Here’s why: Most often than not, biocatalysis projects are pursued without any clear idea of the chances of success. For example: let’s say you have an enzyme development portfolio. You have to decide the next project to invest in, discarding other options from your portfolio. After spending weeks analyzing and defining priorities…you’ll allocate your resources on a project that will take several months and a considerable investment -risking company time and money- only to end up with poor results... …But what if that project just wasn’t the right option to begin with? You have now invested (precious) time and money in something that was meant to fail, while missing better opportunities from your portfolio. Just like you wouldn’t buy a sofa without checking first if it will fit in your living room, when it comes to enzyme development, there are certain specifics worth looking into before betting on a specific option. At @ ZYMVOL we’ve been helping our clients make better decisions in regards to their biocatalysis portfolio through #Zymplifier. Whether to assess the viability of potential routes or enhance enzyme performance, Zymplifier provides clear, data-driven guidance so you can invest only in what is most likely to succeed. What do you think? Can we help spread the application of biocatalysis by making it easier to implement (and succeed)? We believe so! Have a look at how 👇
So many biocatalysis projects end up failing because they were just not meant to be. When it comes to enzyme development, it’s hard to make the right decision without having clarity on the chances of success. Specially, with no reliable data. In the last few months, at ZYMVOL we’ve been envisioning the way to use our prediciting capabilities to solve this issue. And finally, today, we’re presenting #Zymplifier. Zymplifier is our data-driven approach to help all those innovators in the field of green chemistry find out the most promising opportunities in their enzyme development portfolio. Have a look at Zymplifier and start betting on what is most likely to succeed. 👉 https://lnkd.in/d4ACXiQP
-
-
Personal Portfolio Manager | Virtual Portfolio Manager | Swing Trader | Helping people for managing funds. Mission:- Building the financially literate Bharat.
Rossari Biotech A Cup with Handle Formation, Break-out, Break-out confirmation, then retracement. Good business and financials. 👍 #RossariBiotechinvestment #Biotechinvestment #RossariInvestment #InvestinginBiotech #BiotechOpportunity #GrowthinBiotech #RossariInvest #BiotechInvestor #InvestmentOpportunity #RossariBiotech
-
-
🌟 Insights from CirChem's participation at Eminova Partners Corporate Finance AB Day at Inderes where Anton Damstén and our CEO Petra Sas had a chat 🌿 🌍 CirChem = Transforming Industry with Circular Chemistry! ♻️ 🎯 Our Mission: Turning Industrial Solvents into Sustainable Solutions, Over and Over Again 🔁 🚀 Driving Forces: 🌱 Stricter Environmental Laws, Industries Going Green, Rising Demand for Sustainability, and Localized Recycling to Strengthen Supply Chains ⚙️ 🌱 Growing Market: Awareness + Regulations = Increased Demand for Circular Waste Management and Solvent Recycling 📈 ⚡Our Edge: Pioneers in the Nordics 🌟, Turning Waste to Wealth 💰, Mastering Solvent Recovery 🛠️ ⚖️ Challenge: Balancing Tech Investment and Scalability for Future Success 💼 🧭 Strategy: Embrace Tech and Innovation, Expand Reach, Forge Strong Partnerships 🤝 🌟 Our Commitment: Sustained Operational Excellence, Profitable Process Development, and Delivering Shareholder Value 💹 #CirChem #CircularEconomy #Sustainability #Innovation #GrowthStrategy #Eminova #Inderes
Eminova Partners Day - Circhem - Inderes
inderes.se
-
Are you going to Bio International 2024? Let’s meet and discuss how we can help you accelerate your growth in the most diverse BioScience ecosystem in the USA. #Bio2024 “It’s not what’s next, its where”
The countdown is on! 🇵🇷 We're just two weeks away from #BIO2024! Join #InvestPR in San Diego from June 3-6 to explore why #PuertoRico is the destination for #bioscience innovation. Visit us at Booth 2611 to discover the unique opportunities and benefits of doing business on the island. Don’t miss out! Schedule a meeting with us today ▶️ https://loom.ly/jEG7FDQ
-
-
Enhance your Biohacker Summit experience by visiting Audicin HUMAN CHARGING STATION booth. As a guest of Audicin you'll get 10% off the ticket price with the code SUMMITPARTNER. #biohacking #longetivity #nervoussystemregulation #wellbeing #productivity #performance
-
Helping Biotech & Pharmaceutical leadership accelerate their drug discovery efforts and optimize their lab operations. | Senior Account Executive
Scigilian is live at BioIT World 2024. Stop by booth 512 to learn how we can help optimize your lab operations. 🔬🦠#biotech #drugdiscovery #Scigilian
-
-
Join the WEBINAR highlighting the main achievement on the potential of enzymatic plastic recycling!
Three research projects, Bizente, Recover BBI and Enzycle are inviting for a joint #webinar on 📅 17th January 2024, 10:00 AM - 12:00 (CET)! We are demonstrating the power of #enzymes for boosting the #circular #economy in Europe. Let's have a look on the re-use of particular monomeric products and the potential to create new value out of these #recycled components. What was successful? What did not work? In this event we share our lessons learnt. Let's discuss the challenges that might be tackled in the future and the chances that arise from our results. Register here: https://lnkd.in/dZ8hMRZX
